SIEN - Sientra, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.58
-0.42 (-6.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close 7.00
Open 6.89
Bid 6.57 x 1100
Ask 6.66 x 4000
Day's Range 6.56 - 7.03
52 Week Range 4.78 - 26.65
Volume 558,735
Avg. Volume 1,118,346
Market Cap 323.839M
Beta (3Y Monthly) 1.75
PE Ratio (TTM) N/A
EPS (TTM) -3.23
Earnings Date May 4, 2017 - May 8, 2017
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 13.00
Trade prices are not sourced from all markets
  • Thomson Reuters StreetEvents

    Edited Transcript of SIEN earnings conference call or presentation 8-Aug-19 8:30pm GMT

    Q2 2019 Sientra Inc Earnings Call

  • Sientra (SIEN) Q2 2019 Earnings Call Transcript
    Motley Fool

    Sientra (SIEN) Q2 2019 Earnings Call Transcript

    SIEN earnings call for the period ending June 30, 2019.

  • Sientra (SIEN) Reports Q2 Loss, Tops Revenue Estimates
    Zacks

    Sientra (SIEN) Reports Q2 Loss, Tops Revenue Estimates

    Sientra (SIEN) delivered earnings and revenue surprises of -5.80% and 7.18%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Sientra Reports Second Quarter 2019 Financial Results

    Record total net sales of $20.5 million in 2Q19, growth of 17% year over year Breast Products net sales of $11.2 million in 2Q19, growth of 19% year over year Record.

  • Will Sientra (SIEN) Report Negative Earnings Next Week? What You Should Know
    Zacks

    Will Sientra (SIEN) Report Negative Earnings Next Week? What You Should Know

    Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Sientra, Inc. (NASDAQ:SIEN) A Financially Sound Company?
    Simply Wall St.

    Is Sientra, Inc. (NASDAQ:SIEN) A Financially Sound Company?

    Investors are always looking for growth in small-cap stocks like Sientra, Inc. (NASDAQ:SIEN), with a market cap of...

  • GlobeNewswire

    Sientra to Report Second Quarter 2019 Financial Results on August 8, 2019

    Sientra, Inc. (SIEN), a medical aesthetics company, announced today that it will release financial results for the second quarter 2019 after the close of trading on Thursday, August 8, 2019. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time. The dial-in numbers are 844-464-3933 for domestic callers and 765-507-2612 for international callers.

  • Here’s What Hedge Funds Think About Sientra Inc (SIEN)
    Insider Monkey

    Here’s What Hedge Funds Think About Sientra Inc (SIEN)

    Insider Monkey has processed numerous 13F filings of hedge funds and successful investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find write-ups about an individual hedge fund's trades on numerous financial news […]

  • PR Newswire

    Bowes Dermatology by Riverchase is One of First Locations to Offer New miraDry

    MIAMI, June 21, 2019 /PRNewswire/ -- Bowes Dermatology by Riverchase is pleased to announce the launch of breakthrough technology, miraDry. Bowes Dermatology by Riverchase is one of the first locations in the area to provide miraDry, which is clinically proven to eliminate sweat and odor glands. The miraDry system's unique miraWave™ technology delivers precise microwave energy at the dermal-fat interface, to safely heat and destroy sweat and odor glands and hair follicles.

  • Zacks

    Stocks Take Another Small Step Back

    Stocks Take Another Small Step Back

  • GlobeNewswire

    Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares

    Sientra, Inc. (SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously announced underwritten public offering of 17,391,305 shares of its common stock, as well as 2,608,695  additional shares of its common stock pursuant to the full exercise of the option granted to the underwriters. The shares were sold at the public offering price of $5.75 per share and the company estimates the aggregate net proceeds to the company will be approximately $108.1 million, after deducting underwriting discounts and commissions and other estimated offering expenses. Sientra intends to use the net proceeds from this offering to implement sales and marketing initiatives, expand its U.S. and global commercial organizations, fund its research and development efforts, and for general corporate purposes, including general and administrative expenses, capital expenditures and general working capital purposes.

  • Benzinga

    Wells Fargo Upgrades Sientra After FDA, Financing Concerns Ease

    Shares of Sientra Inc (NASDAQ: SIEN ) have declined about 25 percent since the company reported its first-quarter results on May 8. Meanwhile, the industry backdrop has improved and the near-term financing ...

  • GlobeNewswire

    Sientra Announces Pricing of Upsized Public Offering of Common Stock

    Sientra, Inc. (SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the upsizing and pricing of its previously announced underwritten public offering. The Company will sell 17,391,305 shares of its common stock at a public offering price of $5.75 per share. The gross proceeds to Sientra, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $100.0 million.

  • GlobeNewswire

    Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Sientra, Inc. (SIEN) ( “Sientra” or the “Company”), a medical aesthetics company, today announced that on May 30, 2019, the Compensation Committee of the Company’s Board of Directors approved equity award grants under the Sientra, Inc. Inducement Plan to 17 new employees. The new employees were granted restricted stock units representing a total of 89,067 shares of common stock.

  • GlobeNewswire

    Sientra Commences Public Offering of Common Stock

    Sientra, Inc. (SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an underwritten public follow-on offering of approximately $75,000,000 of its common stock to be sold by the Company. In addition, the Company intends to grant the underwriters a 30-day option to purchase up to $11,250,000 of additional shares. Sientra intends to use the net proceeds from this offering to implement sales and marketing initiatives, expand its U.S. and global commercial organizations, fund its research and development efforts, and for general corporate purposes, including general and administrative expenses, capital expenditures and general working capital purposes.

  • Sientra (SIEN) Q1 2019 Earnings Call Transcript
    Motley Fool

    Sientra (SIEN) Q1 2019 Earnings Call Transcript

    SIEN earnings call for the period ending March 31, 2019.

  • Thomson Reuters StreetEvents

    Edited Transcript of SIEN earnings conference call or presentation 8-May-19 8:30pm GMT

    Q1 2019 Sientra Inc Earnings Call

  • Associated Press

    Sientra: 1Q Earnings Snapshot

    The Santa Barbara, California-based company said it had a loss of 91 cents per share. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...

  • GlobeNewswire

    Sientra Reports First Quarter 2019 Financial Results

    First Quarter 2019 Net Sales of $17.6 million, Growth of 20% year over year Provides 2019 Net Sales Outlook of $79 million to $83 million SANTA BARBARA, Calif., May 08, 2019.

  • Sientra (SIEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Zacks

    Sientra (SIEN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Sientra (SIEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Here's Why Sientra's Shares Got a Lift Today
    Motley Fool

    Here's Why Sientra's Shares Got a Lift Today

    The FDA approved a design change for the company's Opus breast implants.

  • GlobeNewswire

    Sientra to Release First Quarter Financial Results on May 8, 2019

    Sientra, Inc. (SIEN), a medical aesthetics company (“Sientra” or the “Company”), announced today that the Company will release its first quarter 2019 financial results on Wednesday, May 8, 2019 after market close. Sientra will hold a conference call on Wednesday, May 8, 2019 at 4:30 p.m. ET to discuss the results. A press release disclosing the Company's financial results will be distributed at approximately 4:00 p.m. ET that same day.

  • Those Who Purchased Sientra (NASDAQ:SIEN) Shares A Year Ago Have A 32% Loss To Show For It
    Simply Wall St.

    Those Who Purchased Sientra (NASDAQ:SIEN) Shares A Year Ago Have A 32% Loss To Show For It

    It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realized by Sientra, Inc. (NASDAQ:SIE...

  • GlobeNewswire

    Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter

    Sientra, Inc. (SIEN), a medical aesthetics company (“Sientra" or the “Company”), today announced it has provided an initial response to the U.S. Food and Drug Administration (“FDA”) related to a post-approval study Warning Letter issued on March 19, 2019 and will provide a comprehensive plan for compliance to FDA within 15 days.